Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_provenance.
- befree-2016 importedOn "2016-02-19" NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_provenance.
- NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_assertion wasGeneratedBy ECO_0000203 NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_provenance.
- NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_assertion wasDerivedFrom befree-2016 NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_provenance.
- NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_assertion SIO_000772 23760401 NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_provenance.
- NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_assertion evidence source_evidence_literature NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_provenance.
- NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_assertion description "[Taken together, our findings support the hypotheses that CD44 and CAM-DR contribute to lenalidomide resistance in multiple myeloma, that CD44 should be evaluated as a putative biomarker of sensitivity to lenalidomide, and that ATRA or other approaches that target CD44 may overcome clinical lenalidomide resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1085337.RAR47AGT9WVPN4Xc9IREiAIxV9SB2fPWeY09Q_4dufm5s130_provenance.